Literature DB >> 16741225

Neural stem cell model for prion propagation.

Ollivier Milhavet1, Danielle Casanova, Nathalie Chevallier, Ronald D G McKay, Sylvain Lehmann.   

Abstract

The study of prion transmission and targeting is a major scientific issue with important consequences for public health. Only a few cell culture systems that are able to convert the cellular isoform of the prion protein into the pathologic scrapie isoform of the prion protein (PrP(Sc)) have been described. We hypothesized that central nervous system neural stem cells (NSCs) could be the basis of a new cell culture model permissive to prion infection. Here, we report that monolayers of differentiated fetal NSCs and adult multipotent progenitor cells isolated from mice were able to propagate prions. We also demonstrated the large influence of neural cell fate on the production of PrP(Sc), allowing the molecular study of prion neuronal targeting in relation with strain differences. This new stem cell-based model, which is applicable to different species and to transgenic mice, will allow thoughtful investigations of the molecular basis of prion diseases, and will open new avenues for diagnostic and therapeutic research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741225     DOI: 10.1634/stemcells.2006-0088

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  14 in total

1.  Establishment and characterization of Prnp knockdown neuroblastoma cells using dual microRNA-mediated RNA interference.

Authors:  Sang-Gyun Kang; Yu-Mi Roh; Agnes Lau; David Westaway; Debbie McKenzie; Judd Aiken; Yong-Sun Kim; Han Sang Yoo
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

2.  Prion replication elicits cytopathic changes in differentiated neurosphere cultures.

Authors:  Yoshifumi Iwamaru; Takato Takenouchi; Morikazu Imamura; Yoshihisa Shimizu; Kohtaro Miyazawa; Shirou Mohri; Takashi Yokoyama; Hiroshi Kitani
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

3.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.

Authors:  Sophie Mouillet-Richard; Noriyuki Nishida; Elodie Pradines; Hubert Laude; Benoît Schneider; Cécile Féraudet; Jacques Grassi; Jean-Marie Launay; Sylvain Lehmann; Odile Kellermann
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

5.  Chronic wasting disease prion infection of differentiated neurospheres.

Authors:  Yoshifumi Iwamaru; Candace K Mathiason; Glenn C Telling; Edward A Hoover
Journal:  Prion       Date:  2017-08-01       Impact factor: 3.931

Review 6.  Susceptibility of cell substrates to PrPSc infection and safety control measures related to biological and biotherapeutical products.

Authors:  Matthew LeBrun; Hongsheng Huang; Xuguang Li
Journal:  Prion       Date:  2008-01-13       Impact factor: 3.931

Review 7.  Cellular aspects of prion replication in vitro.

Authors:  Andrea Grassmann; Hanna Wolf; Julia Hofmann; James Graham; Ina Vorberg
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

8.  Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.

Authors:  Zuzana Krejciova; Paul De Sousa; Jean Manson; James W Ironside; Mark W Head
Journal:  Am J Pathol       Date:  2013-11-01       Impact factor: 4.307

9.  Cerebral organoids as a new model for prion disease.

Authors:  Bradley R Groveman; Anna Smith; Katie Williams; Cathryn L Haigh
Journal:  PLoS Pathog       Date:  2021-07-21       Impact factor: 6.823

10.  Gene organization, evolution and expression of the microtubule-associated protein ASAP (MAP9).

Authors:  Magali Venoux; Karine Delmouly; Ollivier Milhavet; Sophie Vidal-Eychenié; Dominique Giorgi; Sylvie Rouquier
Journal:  BMC Genomics       Date:  2008-09-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.